Free Trial
NYSE:NUS

Nu Skin Enterprises (NUS) Stock Price, News & Analysis

$8.00
-0.35 (-4.19%)
(As of 09/6/2024 ET)
Today's Range
$8.00
$8.45
50-Day Range
$8.01
$11.22
52-Week Range
$8.00
$24.38
Volume
699,869 shs
Average Volume
745,415 shs
Market Capitalization
$397.34 million
P/E Ratio
N/A
Dividend Yield
3.00%
Price Target
$16.50

Nu Skin Enterprises MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
106.3% Upside
$16.50 Price Target
Short Interest
Healthy
5.49% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-2.56
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
34.62%
From $0.78 to $1.05 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.81 out of 5 stars

Consumer Staples Sector

46th out of 136 stocks

Drugs, Proprietaries, & Sundries Industry

5th out of 6 stocks

NUS stock logo

About Nu Skin Enterprises Stock (NYSE:NUS)

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

NUS Stock Price History

NUS Stock News Headlines

Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳
45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open.
Nu Skin's (NYSE:NUS) Q2 Sales Beat Estimates
Nu Skin Enterprises Reports Second Quarter Results
Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳
45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open.
Sell These 3 Stocks Before the Upcoming Recession
Escape the Downturn: 3 Must-Sell Stocks Before July
See More Headlines
Receive NUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nu Skin Enterprises and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 6/12 Dividend
5/31/2024
Dividend Payable
6/12/2024
Last Earnings
8/08/2024
Ex-Dividend for 9/11 Dividend
8/30/2024
Today
9/07/2024
Dividend Payable
9/11/2024
Next Earnings (Estimated)
11/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
Personal Products
CUSIP
67018T10
Employees
3,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$16.50
High Stock Price Target
$27.00
Low Stock Price Target
$11.00
Potential Upside/Downside
+106.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$8.60 million
Pretax Margin
-8.44%

Debt

Sales & Book Value

Annual Sales
$1.84 billion
Cash Flow
$2.95 per share
Book Value
$13.81 per share

Miscellaneous

Free Float
48,823,000
Market Cap
$397.34 million
Optionable
Optionable
Beta
1.13
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Key Executives

  • Mr. Steven J. Lund (Age 71)
    Co-Founder & Executive Chairman of the Board
    Comp: $856.61k
  • Mr. Ryan S. Napierski (Age 50)
    President, CEO & Director
    Comp: $1.79M
  • Mr. James D. Thomas (Age 45)
    Executive VP, Chief Accounting Officer & CFO
    Comp: $689.3k
  • Dr. Joseph Y. Chang Ph.D. (Age 71)
    Executive VP & Chief Scientific Officer
    Comp: $1.12M
  • Mr. Chayce David Clark (Age 41)
    Executive VP & General Counsel
    Comp: $896.47k
  • Mr. Steve Keith Hatchett (Age 52)
    Executive VP & Chief Product Officer
    Comp: $633.26k
  • Ms. Mang Yee Tang (Age 53)
    Strategic Advisor
    Comp: $1.19M
  • Mr. Blake M. Roney (Age 65)
    Founder
    Comp: $621.69k
  • Ms. Sandra N. Tillotson (Age 67)
    Founder
    Comp: $1.06M
  • Mr. Joe Sueper
    Senior VP & CTO

NUS Stock Analysis - Frequently Asked Questions

How have NUS shares performed this year?

Nu Skin Enterprises' stock was trading at $19.42 at the start of the year. Since then, NUS stock has decreased by 58.8% and is now trading at $8.00.
View the best growth stocks for 2024 here
.

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) posted its earnings results on Thursday, August, 8th. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.04. The business's quarterly revenue was down 12.2% on a year-over-year basis.

What is Ritch Wood's approval rating as Nu Skin Enterprises' CEO?

72 employees have rated Nu Skin Enterprises Chief Executive Officer Ritch Wood on Glassdoor.com. Ritch Wood has an approval rating of 91% among the company's employees. This puts Ritch Wood in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are Nu Skin Enterprises' major shareholders?

Top institutional investors of Nu Skin Enterprises include Pacer Advisors Inc. (4.82%), Renaissance Technologies LLC (3.54%), Federated Hermes Inc. (2.66%) and Dimensional Fund Advisors LP (1.89%). Insiders that own company stock include Ryan S Napierski, Steven Keith Hatchett, Mark H Lawrence, Andrew D Lipman, Joseph Y Chang, Steven Lund, Edwina D Woodbury, James D Thomas, Laura Nathanson, Emma S Battle and Jeffrey Clark Bettinger.
View institutional ownership trends
.

How do I buy shares of Nu Skin Enterprises?

Shares of NUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Nu Skin Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), NVIDIA (NVDA), Marathon Petroleum (MPC), Gilead Sciences (GILD), Alphabet (GOOG) and Tesla (TSLA).

This page (NYSE:NUS) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners